The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Mechanisms of Action of Antiepileptic Drugs
Abstract
Gamma-aminobutyric acid (GABA), one of the main inhibitory neurotransmitters in the brain, interacts with three types of receptors for GABA--GABA(A), GABA(B) and GABA(C). GABA(A) receptors, associated with binding sites for benzodiazepines and barbiturates in the form of a receptor complex, control opening of the chloride channel. When GABA binds to the receptor complex, the channel is opened and chloride anions enter the neuron, which is finally hyperpolarized. GABA(B) receptors are metabotropic, linked to a cascade of second messengers whilst the physiological meaning of ionotropic GABA(C) receptors, mainly located in the retina, is generally unknown. Novel antiepileptic drugs acting selectively through the GABA-ergic system are tiagabine and vigabatrin. The former inhibits neuronal and glial uptake of GABA whilst the latter increases the synaptic concentration of GABA by inhibition of GABA-aminotransferase. Gabapentin, designed as a precursor of GABA easily entering the brain, was shown to increase brain synaptic GABA. This antiepileptic drug also decreases influx of calcium ions into neurons via a specific subunit of voltage-dependent calcium channels. Conventional antiepileptics generally inhibit sodium currents (carbamazepine, phenobarbital, phenytoin, valproate) or enhance GABA-ergic inhibition (benzodiazepines, phenobarbital, valproate). Ethosuximide, mainly controlling absences, reduces calcium currents via T-type calcium channels. Novel antiepileptic drugs, mainly associated with an inhibition of voltage-dependent sodium channels are lamotrigine and oxcarbazepine. Since glutamate-mediated excitation is involved in the generation of seizure activity, some antiepileptics are targeting glutamatergic receptors--for instance, felbamate, phenobarbital, and topiramate. Besides, they also inhibit sodium currents. Zonisamide, apparently sharing this common mechanism, also reduces the concentration of free radicals. Novel antiepileptic drugs are better tolerated by epileptic patients and practically are devoid of important pharmacokinetic drug interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabotropic glutamate receptors: Structure and functions
Pin, J.-P., & Duvoisin, R. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00129-g · Cited by 2,266
Monaghan, D. T., Bridges, R. J., & Cotman, C. W. (1989) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.002053 · Cited by 2,194
The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel
Gee, N. S., Brown, J. P., Dissanayake, V. U. K., Offord, J., Thurlow, R., & Woodruff, G. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5768 · Cited by 1,181
Watkins, J. C., Korgsgaard-Larsen, P., & Honoré, T. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90038-a · Cited by 901
Anticonvulsant Action of Excitatory Amino Acid Antagonists
Croucher, M. J., Collins, J. F., & Meldrum, B. S. (1982) · Science · doi:10.1126/science.7079744 · Cited by 695
Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.10.008 · Cited by 477
Genetic absence epilepsy in rats from Strasbourg — A review
Marescaux, C., Vergnes, M., & Depaulis, A. (1992) · Generalized Non-Convulsive Epilepsy: Focus on GABA-B Receptors · doi:10.1007/978-3-7091-9206-1_4 · Cited by 434
Topiramate: Preclinical Evaluation of a Structurally Novel Anticonvulsant
Shank, R. P., Gardocki, J. F., Vaught, J. L., Davis, C. B., Schupsky, J. J., Raffa, R. B., Dodgson, S. J., Nortey, S. O., & Maryanoff, B. E. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02459.x · Cited by 345
Glutamate receptors: brain function and signal transduction
Nakanishi, S., Nakajima, Y., Masu, M., Ueda, Y., Nakahara, K., Watanabe, D., Yamaguchi, S., Kawabata, S., & Okada, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00033-7 · Cited by 339
Selection of Antiepileptic Drug Polytherapy Based on Mechanisms of Action: The Evidence Reviewed
Deckers, C. L. P., Czuczwar, S. J., Hekster, Y. A., Kewser, A., Kubova, H., Meinardi, H., Patsalos, P. N., Renier, W. O., & Van Rijn, C. M. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00111.x · Cited by 331
Self-citationGroup I metabotropic glutamate receptors: implications for brain diseases
Bordi, F., & Ugolini, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00095-1 · Cited by 295
New visions in the pharmacology of anticonvulsion
Löscher, W. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01514-8 · Cited by 269
Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid
Czuczwar, S. J., & Meldrum, B. S. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90273-4 · Cited by 256
Self-citationUpdate on the Mechanism of Action of Antiepileptic Drugs
Meldrum, B. S. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb06038.x · Cited by 247
Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders
Gasior, M., Carter, R. B., & Witkin, J. M. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01318-8 · Cited by 218
Ben-Ari, Y., Lagowska, J., Tremblay, E., & Le Gal La Salle, G. (1979) · Brain Research · doi:10.1016/0006-8993(79)90163-x · Cited by 212
The New Generation of GABA Enhancers: Potential in the Treatment of Epilepsy
Czuczwar, S. J., & Patsalos, P. N. (2001) · CNS Drugs · doi:10.2165/00023210-200115050-00001 · Cited by 209
Self-citationSchechter, P. J., Tranier, Y., Jung, M. J., & Böhlen, P. (1977) · European Journal of Pharmacology · doi:10.1016/0014-2999(77)90270-9 · Cited by 202
Sofia, R. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360423 · Cited by 194
Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain
Löscher, W., Hönack, D., & Taylor, C. P. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90249-s · Cited by 193
Kindling: An animal model of complex partial epilepsy
McNamara, J. O. (1984) · Annals of Neurology · doi:10.1002/ana.410160712 · Cited by 190
Miller, A. A., Wheatley, P., Sawyer, D. A., Baxter, M. G., & Roth, B. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb03572.x · Cited by 182
Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00108-9 · Cited by 179
Amino Acid Neurotransmitters and New Approaches to Anticonvulsant Drug Action
Meldrum, B. (1984) · Epilepsia · doi:10.1111/j.1528-1157.1984.tb05646.x · Cited by 176
Smith, S. E., Durmuller, N., & Meldrum, B. S. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90342-n · Cited by 174
Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00106-7 · Cited by 172
Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy
Binnie, C. D., Debets, R. M. C., Engelsman, M., Meijer, J. W. A., Meinardi, H., Overweg, J., Peck, A. W., Van Wieringen, A., & Yuen, W. C. (1989) · Epilepsy Research · doi:10.1016/0920-1211(89)90007-7 · Cited by 169
Loiseau, P., Yuen, A. W. C., Duché, B., Ménager, T., & Arné-Bès, M. C. (1990) · Epilepsy Research · doi:10.1016/0920-1211(90)90099-h · Cited by 163
Olney, J. W., Farber, N. B., Wozniak, D. F., Jevtović‐Todorović, V., & Ikonomidou, C. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3383 · Cited by 157
Hosford, D. A., & Wang, Y. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01729.x · Cited by 150
Opposite effects of GABAB receptor antagonists on absences and convulsive seizures
Vergnes, M., Boehrer, A., Simler, S., Bernasconi, R., & Marescaux, C. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01085-6 · Cited by 141
Voltage‐Activated Calcium Channels: Targets of Antiepileptic Drug Therapy?
Stefani, A., Spadoni, F., & Bernardi, G. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01477.x · Cited by 138
Molecular composition of GABAC receptors
Enz, R., & Cutting, G. R. (1998) · Vision Research · doi:10.1016/s0042-6989(97)00277-0 · Cited by 134
Dalby, N. O., & Nielsen, E. B. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00031-4 · Cited by 126
Adkins, J. C., & Noble, S. (1998) · Drugs · doi:10.2165/00003495-199855030-00013 · Cited by 121
Oxcarbazepine: An Update of its Efficacy in the Management of Epilepsy
Wellington, K., & Goa, K. L. (2001) · CNS Drugs · doi:10.2165/00023210-200115020-00005 · Cited by 119
Properties of vertebrate glutamate receptors: Calcium mobilization and desensitization
Zorumski, C. F., & Thio, L. L. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90020-f · Cited by 118
Mechanisms of action of new antiepileptic drugs
Macdonald, R. L., & Greenfield, L. J. (1997) · Current Opinion in Neurology · doi:10.1097/00019052-199704000-00009 · Cited by 103
Tiagabine-induced absence status in idiopathic generalized epilepsy
Knake, S., Hamer, H. M., Schomburg, U., Oertel, W. H., & Rosenow, F. (1999) · Seizure · doi:10.1053/seiz.1999.0303 · Cited by 101
GAMMA-AMINOBUTYRIC ACID AND THE SEARCH FOR NEW ANTICONVULSANT DRUGS
Meldrum, B. S. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91703-8 · Cited by 91
Felbamate block of recombinant N-methyl-d-aspartate receptors: selectivity for the NR2B subunit
Harty, T. P., & Rogawski, M. A. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(99)00108-4 · Cited by 90
Turski, L., Jacobsen, P., Honoré, T., et al. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11359-1 · Cited by 86
Klitgaard, H., & Pitkänen, A. (2003) · Epileptic Disorders · doi:10.1684/j.1950-6945.2003.tb00025.x · Cited by 82
Łuszczki, J. J., Czuczwar, M., Kiś, J., Krysa, J., Pasztelan, I., Świąder, M., & Czuczwar, S. J. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.10003.x · Cited by 75
Self-citationGetova, D. P., Bowery, N. G., & Spassov, V. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00877-1 · Cited by 71
Caffeinated beverages and decreased seizure control
Kaufman, K. R., & Sachdeo, R. C. (2003) · Seizure · doi:10.1016/s1059-1311(03)00048-7 · Cited by 71
Borowicz, K. K., Świąder, M., Łuszczki, J. J., & Czuczwar, S. J. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.34301.x · Cited by 70
Self-citationNeuroprotective effects of antiepileptic drugs.
Trojnar, M. K., Małek, R., Chrościńska, M., et al. (2003) · PubMed · Cited by 69
Turski, L., Niemann, W., & Stephens, D. N. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90262-3 · Cited by 63
Patsalos, P. N. (1999) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329903600102 · Cited by 57
Inappropriate use of carbamazepine and vigabatrin in typical absence seizures
Parker, A. P. J., Agathonikou, A., Robinson, R. O., & Panayiotopoulos, C. P. (1998) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1998.tb15409.x · Cited by 56
Kälviäinen, R. K., Halonen, T., Pitkänen, A., & Riekkinen, P. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03283.x · Cited by 55
Effect of Anticonvulsant Felbamate on GABAA Receptor System
Ticku, M. K., Kamatchi, G. L., & Sofia, R. D. (1991) · Epilepsia · doi:10.1111/j.1528-1157.1991.tb04667.x · Cited by 48
Pitkänen, A., Tuunanen, J., & Halonen, T. (1996) · Epilepsy Research · doi:10.1016/0920-1211(95)00093-3 · Cited by 48
Czuczwar, S. J., Ga̧sior, M., Janusz, W., Szczepanik, B., Wlodarczyk, D., & Kleinrok, Z. (1990) · Epilepsia · doi:10.1111/j.1528-1157.1990.tb05382.x · Cited by 47
Self-citationPuigcerver, A., van Luijtelaar, E. L. J. M., Drinkenburg, W. H. I. M., & Coenen, A. M. L. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(96)00046-9 · Cited by 46
Felbamate inhibits cloned voltage-dependent Na+ channels from human and rat brain
Taglialatela, M., Ongini, E., Brown, A. M., Renzo, G. D., & Annunziato, L. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00802-3 · Cited by 43
Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice
Sarro, G. D., Spagnolo, C., Gareri, P., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00193-9 · Cited by 41
Getova, D. P., Froestl, W., & Bowery, N. G. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00864-6 · Cited by 39
Low-Dose Vigabatrin (γ-Vinyl GABA)-Induced Damage in the Immature Rat Brain
Sidhu, R. S., Bigio, M. R. D., Tuor, U. I., & Seshia, S. S. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6412 · Cited by 38
Mechanism of action of valproate
Meldrum, B. S. (1980) · Brain Research Bulletin · doi:10.1016/0361-9230(80)90094-5 · Cited by 37
Pharmacoresistance: Modern Concept and Basic Data Derived from Human Brain Tissue
Elger, C. E. (2003) · Epilepsia · doi:10.1046/j.1528-1157.44.s.5.3.x · Cited by 30
Ebert, U., Reißmüller, E., & Löscher, W. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00039-3 · Cited by 30
Ga̧sior, M., Borowicz, K. K., Buszewicz, G., Kleinrok, Z., & Czuczwar, S. A. J. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00023.x · Cited by 24
Self-citationChronic caffeine and the anticonvulsant potency of antiepileptic drugs against maximal electroshock
Ga̧sior, M., Borowicz, K. K., Kleinrok, Z., & CZUCZWAR, S. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02222-8 · Cited by 23
Self-citationNicotine diminishes anticonvulsant activity of antiepileptic drugs in mice.
Czuczwar, M., Kiś, J., Czuczwar, P., Wielosz, M., & Turski, W. A. (2003) · PubMed · Cited by 18
Long-term follow-up study of vigabatrin in pretreated children with west syndrome
Siemes, H., Brandl, U., Spohr, H. L., Völger, S., & Weschke, B. (1998) · Seizure · doi:10.1016/s1059-1311(98)80021-6 · Cited by 17
Recent advances in the GABA-A-benzodiazepine receptor pharmacology.
Kostowski, W. (1996) · PubMed · Cited by 11
Cited by
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Valproate: Past, Present, and Future
Johannessen, C. U., & Johannessen, S. I. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00249.x · Cited by 363
Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet
Rogawski, M. A., Löscher, W., & Rho, J. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022780 · Cited by 336
Johannessen Landmark, C. (2008) · CNS Drugs · doi:10.2165/00023210-200822010-00003 · Cited by 316
Fontana, B. D., Mezzomo, N. J., Kalueff, A. V., & Rosemberg, D. B. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.004 · Cited by 272
Metadata
- Authors
- Czapinski, P., Blaszczyk, B., & Czuczwar, S.
- Venue
- Current Topics in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2005-01-01
- Volume
- 5
- Issue
- 1
- Pages
- 3-14
- ISSN
- 1568-0266 (ISSN-L)
- OpenAlex
- W2104894228
- Cited by
- 382
- References
- 68
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.